StockIQpro
NASDAQ:PGNY

Progyny, Inc.

Progyny, Inc.'s revenue grew 10.4% in fiscal 2025 to $1.3B while operating margin rose to 6.6%, its highest in 9 years. Free cash flow was $191.8M, 14.9% of revenue, and the diluted share count fell 5.9%.Summary generated from Progyny, Inc.'s SEC filings. Latest annual report filed Feb 27, 2026.

Revenue (FY25)$1.3B
Revenue growth+10.4%
Revenue, 5-yr CAGR+30.2%
Gross margin23.6%
Operating margin6.6%
Net margin4.5%
ROICn/a
Return on equity12.5%
Debt / equityn/a
Free cash flow$191.8M
FCF margin14.9%
Share count change−5.9%

Financials

Fiscal years, $M
Item20212022202320242025
Revenue5017871,0891,1671,289
Operating income3223626785
Net income6630625459
Free cash flow2477185174192

Recent filings

From SEC EDGAR

Peers

Services: misc health & allied services, nec